Alkem Laboratories is reportedly planning to raise an estimated Rs. 1,500-3,500 crore through an initial public offering.
A report says that the company is expected to be valued at around Rs. 15,000 crore.
The company will file its draft paper with capital market regulator Securities and Exchange Board of India (Sebi) to float an IPO, says report.
The move follows the blockbuster IPO of Syngene International, biotechnology major Biocon's research arm.